Bird Flu Market Growth Driven by Rising Poultry Disease Outbreaks and Government Vaccination Programs

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others), By Animal Type (Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Bird Flu Market is valued at US$ 1.41 Bn in 2023, and it is expected to reach US$ 2.17 Bn by 2031, with a CAGR of 5.82% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2347

Avian influenza, commonly referred to as bird flu, is a viral disease that primarily affects avian species but has also demonstrated the capacity to infect humans and certain other animals. Although it shares some characteristics with seasonal human influenza viruses, avian influenza is typically more severe and highly pathogenic in bird populations. Growth in the global avian influenza market is anticipated to be supported by increased government funding for the development of effective preventive and therapeutic solutions, as well as rising mortality rates in poultry resulting from recurring viral outbreaks.

Market dynamics are influenced by several factors, including the emergence of new viral variants, changes in poultry production and farming practices, global trade activities, and ongoing advancements in veterinary medicine and healthcare technologies. While cases of human infection remain limited, the risk of widespread outbreaks and the significant economic and operational consequences for the poultry industry highlight the need for sustained disease surveillance, public health preparedness, and comprehensive risk mitigation strategies.

List of Prominent Players in the Bird Flu Market
• Boehringer Ingelheim
• Ceva Santé Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Venkys
• Anicon Labor GmbH
• Bioveta
• Lohmann Animal Health
• Biogenesis Bago
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Mallinckrodt
• GlaxoSmithKline plc
• Novartis AG
• Bayer AG
• Eli Lilly and Company
• AstraZeneca
• Johnson & Johnson Private Limited
• Bimeda, Inc.
• Phibro Animal Health Corporation
• Medion
• Other prominent players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
Global consumption of animal protein, including poultry, pork, and other meat products, has increased markedly in recent years, driven by population growth and evolving dietary preferences. The resulting expansion of livestock and poultry populations has heightened vulnerability to infectious diseases, particularly avian influenza among species such as chickens and ducks.

Both migratory wild birds-such as ducks, geese, and shorebirds-and domesticated poultry play a significant role in the transmission of avian influenza viruses. Seasonal migration patterns contribute to the spread of these pathogens across broad geographic regions, underscoring the importance of continuous monitoring and surveillance of both wild and farmed bird populations to support effective disease management and risk mitigation strategies.

Challenges:
The control and prevention of avian influenza are associated with multiple challenges. Large-scale culling of infected poultry, a widely used containment measure, often leads to substantial economic losses for producers and may face resistance from local stakeholders. Public skepticism and limited acceptance of vaccination and preventive interventions, frequently influenced by misinformation, further hinder disease control efforts.

In addition, identifying outbreak sources is complicated by informal or unregulated live poultry trade, particularly within traditional market systems. High costs related to vaccine research and development, regulatory compliance, clinical evaluation, and large-scale testing also present significant barriers to broader market growth in avian influenza prevention and management solutions.

Regional Trends:
North America currently holds a leading position in the avian influenza prevention and control market, supported by the presence of established vaccine and diagnostic manufacturers and large-scale poultry operations across the United States and Canada. Strict food safety standards and well-developed biosecurity frameworks further encourage the adoption of advanced disease monitoring and control technologies.

In contrast, the Asia-Pacific region is expected to register the fastest growth, driven by high levels of poultry production and consumption in countries such as China, India, and Vietnam. The region's increased exposure to avian influenza outbreaks, often associated with migratory bird activity, is prompting greater investment in surveillance, vaccination, and containment initiatives, thereby accelerating market expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2347

Recent Developments:
• In July 2023, The vaccination campaign scheduled to commence in October 2023 in France chosen Boehringer Ingelheim, a German company, to supply the required quantity of 80 million doses of avian influenza vaccines. By commencing this campaign, France achieved the distinction of being the inaugural member state of the European Union to immunize poultry against avian influenza. Positive test results for vaccines manufactured in France by Ceva Animal Health and Boehringer Ingelheim were reported by officials of the Ministry of Agriculture last month.

Segmentation of Bird Flu Market -
By Virus Type:
• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• Others
By Test Type:
• PCR Tests
• ELISA Tests
• Hemagglutination Assays
• Virus Isolation Tests
• Next Generation Sequencing
• Others
By Treatment Type:
• Vaccines
• Antiviral Medication
• Immunomodulators
• Others
By Animal Type:
• Chickens
• Ducks
• Geese & Swans
• Pigeons
• Guinea Fowls
• Turkeys
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/bird-flu-market/2347

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.